🇺🇸 FDA
Pipeline program

HTX-034

HTX-034-101

Phase 2 small_molecule completed

Quick answer

HTX-034 for Bunions is a Phase 2 program (small_molecule) at HERON THERAPEUTICS, INC. /DE/ with 1 ClinicalTrials.gov record(s).

Program details

Company
HERON THERAPEUTICS, INC. /DE/
Indication
Bunions
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials